14403-3400 : Liraglutide 18 mg/3ml Subcutaneous Injection, Solution


NDC: 14403-3400
Labeler: Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
Product Type: Human Prescription Drug
Drug Name:  Liraglutide
Dosage Form: Subcutaneous Injection, Solution
Application #: ANDA215503
Rev. Date: 


NDC Package Codes:

  • 14403-3400-1: 3 ML IN 1 SYRINGE, PLASTIC (14403‑3400‑1)
  • 14403-3400-2: 2 SYRINGE, PLASTIC IN 1 CARTON (14403‑3400‑2) / 3 ML IN 1 SYRINGE, PLASTIC (14403‑3400‑1)
  • 14403-3400-3: 3 SYRINGE, PLASTIC IN 1 CARTON (14403‑3400‑3) / 3 ML IN 1 SYRINGE, PLASTIC (14403‑3400‑1)

Active Ingredients:

  • Liraglutide

Dosage Strength:

  • 18 mg/3mL

Pharmaceutical Classes:

  • GLP-1 Receptor Agonist [EPC]
  • Glucagon-Like Peptide 1 [CS]
  • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0143-9144 Liraglutide 6 mg/ml Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
  • 0480-3667 Liraglutide 6 mg/ml Subcutaneous Injection by Teva Pharmaceuticals USA, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 14403-3400 QR Code

< Prev: 14362-0111Next: 14445-104 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.